By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Auspex Pharmaceuticals 

1261 Liberty Way
Suite C
Vista  California  92081-8356  U.S.A.
Phone: 760-599-1800 Fax: 760-599-1801


SEARCH JOBS


Industry
Pharmaceutical






Company News
Results Of Auspex Pharmaceuticals (ASPX)' Phase 3 Registration Trial Of SD-809 To Be Presented At American Academy of Neurology Annual Meeting 3/27/2015 6:09:54 AM
Auspex Pharmaceuticals (ASPX) Reports Fourth Quarter 2014 Results And Business Highlights 3/17/2015 7:34:09 AM
Auspex Pharmaceuticals (ASPX) To Present At The Cowen and Company Healthcare Conference 2/23/2015 7:37:34 AM
Auspex Pharmaceuticals (ASPX) Completes Enrollment In A Pivotal Clinical Trial Of SD-809 In Tardive Dyskinesia 2/3/2015 9:16:39 AM
Auspex Pharmaceuticals (ASPX) To Present At The 2015 Leerink Global Healthcare Conference 2/3/2015 7:52:32 AM
Auspex Pharmaceuticals (ASPX) Announces Closing Of Public Offering Of Common Stock And Full Exercise Of Underwriters' Option To Purchase Additional Shares 1/29/2015 7:42:55 AM
Auspex Pharmaceuticals (ASPX) Announces Pricing Of Follow On Offering 1/23/2015 7:19:53 AM
Auspex Pharmaceuticals (ASPX) Announces Proposed Public Offering Of Common Stock 1/22/2015 7:34:55 AM
Auspex Pharmaceuticals (ASPX) Receives FDA Orphan Drug Designation Of SD-809 For Treatment Of Tourette Syndrome In The Pediatric Population 1/15/2015 7:04:55 AM
Auspex Pharmaceuticals (ASPX) Announces SD-1077 Program For The Potential Treatment Of Parkinson's Disease And Related Movement Disorders 1/12/2015 7:34:41 AM
12345
//-->